These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 34818177)
1. Monotherapy for nonvalvular A-fib with stable CAD? Garigan TP; Earwood JS; Poplawski M J Fam Pract; 2021 Oct; 70(8):403-407. PubMed ID: 34818177 [TBL] [Abstract][Full Text] [Related]
2. Meta-Analysis of Oral Anticoagulant Monotherapy as an Antithrombotic Strategy in Patients With Stable Coronary Artery Disease and Nonvalvular Atrial Fibrillation. Lee SR; Rhee TM; Kang DY; Choi EK; Oh S; Lip GYH Am J Cardiol; 2019 Sep; 124(6):879-885. PubMed ID: 31311662 [TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of anticoagulant monotherapy in atrial fibrillation and stable coronary artery disease: A systematic review and meta-analysis. Ullah W; Sattar Y; Shaukat M; Fischman DL Eur J Intern Med; 2020 Nov; 81():54-59. PubMed ID: 32709546 [TBL] [Abstract][Full Text] [Related]
4. Clinical Outcomes of Rivaroxaban Monotherapy in Heart Failure Patients With Atrial Fibrillation and Stable Coronary Disease: Insights From the AFIRE Trial. Yazaki Y; Nakamura M; Iijima R; Yasuda S; Kaikita K; Akao M; Ako J; Matoba T; Miyauchi K; Hagiwara N; Kimura K; Hirayama A; Matsui K; Ogawa H; Circulation; 2021 Oct; 144(17):1449-1451. PubMed ID: 34694893 [No Abstract] [Full Text] [Related]
5. The efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and coronary artery disease: A meta-analysis of randomized trials. Zelniker TA; Ruff CT; Antman EM; Giugliano RP Eur Heart J Acute Cardiovasc Care; 2019 Sep; 8(6):554-561. PubMed ID: 30318902 [TBL] [Abstract][Full Text] [Related]
6. Antithrombotic therapy in coronary artery disease patients with atrial fibrillation. Wei L; Su E; Liu W; Xing W; Liu X; Zhang Y; Wang S; Cheng Q; Qi D; Gao C BMC Cardiovasc Disord; 2020 Jul; 20(1):323. PubMed ID: 32631244 [TBL] [Abstract][Full Text] [Related]
7. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease. Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080 [TBL] [Abstract][Full Text] [Related]
8. Vitamin K antagonists with or without long-term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events. Lemesle G; Ducrocq G; Elbez Y; Van Belle E; Goto S; Cannon CP; Bauters C; Bhatt DL; Steg PG; Clin Cardiol; 2017 Oct; 40(10):932-939. PubMed ID: 28692742 [TBL] [Abstract][Full Text] [Related]
9. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study. Lamberts M; Gislason GH; Lip GY; Lassen JF; Olesen JB; Mikkelsen AP; Sørensen R; Køber L; Torp-Pedersen C; Hansen ML Circulation; 2014 Apr; 129(15):1577-85. PubMed ID: 24470482 [TBL] [Abstract][Full Text] [Related]
10. Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation: Insights From the PIONEER AF-PCI Trial. Kerneis M; Yee MK; Mehran R; Nafee T; Bode C; Halperin JL; Peterson ED; Verheugt FWA; Wildgoose P; van Eickels M; Lip GYH; Cohen M; Fox KAA; Gibson CM Circ Cardiovasc Interv; 2019 Nov; 12(11):e008160. PubMed ID: 31707805 [TBL] [Abstract][Full Text] [Related]
11. Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial Subanalysis. Ten Berg JM; de Veer A; Oldgren J; Steg PG; Zateyshchikov DA; Jansky P; Seung KB; Hohnloser SH; Lip GYH; Nordaby M; Kleine E; Bhatt DL; Cannon CP; JACC Cardiovasc Interv; 2019 Dec; 12(23):2331-2341. PubMed ID: 31806214 [TBL] [Abstract][Full Text] [Related]
12. Atrial fibrillation and ischemic events with rivaroxaban in patients with stable coronary artery disease (AFIRE): Protocol for a multicenter, prospective, randomized, open-label, parallel group study. Yasuda S; Kaikita K; Ogawa H; Akao M; Ako J; Matoba T; Nakamura M; Miyauchi K; Hagiwara N; Kimura K; Hirayama A; Matsui K Int J Cardiol; 2018 Aug; 265():108-112. PubMed ID: 29764706 [TBL] [Abstract][Full Text] [Related]
13. Outcomes of Cardiac Catheterization in Patients With Atrial Fibrillation on Anticoagulation in Contemporary in Practice: An Analysis of the ORBIT II Registry. Sherwood MW; Piccini JP; Holmes DN; Pieper KS; Steinberg BA; Fonarow GC; Allen LA; Naccarelli GV; Kowey PR; Gersh BJ; Mahaffey KW; Singer DE; Ansell JE; Freeman JV; Chan PS; Reiffel JA; Blanco R; Peterson ED; Rao SV Circ Cardiovasc Interv; 2020 May; 13(5):e008274. PubMed ID: 32408815 [TBL] [Abstract][Full Text] [Related]
14. Combined aspirin and anticoagulant therapy in patients with atrial fibrillation. So CH; Eckman MH J Thromb Thrombolysis; 2017 Jan; 43(1):7-17. PubMed ID: 27665101 [TBL] [Abstract][Full Text] [Related]
15. Rivaroxaban monotherapy versus combination therapy according to patient risk of stroke and bleeding in atrial fibrillation and stable coronary disease: AFIRE trial subanalysis. Akao M; Yasuda S; Kaikita K; Ako J; Matoba T; Nakamura M; Miyauchi K; Hagiwara N; Kimura K; Hirayama A; Matsui K; Ogawa H Am Heart J; 2021 Jun; 236():59-68. PubMed ID: 33657403 [TBL] [Abstract][Full Text] [Related]
16. Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation. Matsumura-Nakano Y; Shizuta S; Komasa A; Morimoto T; Masuda H; Shiomi H; Goto K; Nakai K; Ogawa H; Kobori A; Kono Y; Kaitani K; Suwa S; Aoyama T; Takahashi M; Sasaki Y; Onishi Y; Mano T; Matsuda M; Motooka M; Tomita H; Inoko M; Wakeyama T; Hagiwara N; Tanabe K; Akao M; Miyauchi K; Yajima J; Hanaoka K; Morino Y; Ando K; Furukawa Y; Nakagawa Y; Nakao K; Kozuma K; Kadota K; Kimura K; Kawai K; Ueno T; Okumura K; Kimura T; Circulation; 2019 Jan; 139(5):604-616. PubMed ID: 30586700 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Antiplatelet Therapy Plus Xa Factor Inhibitors in Patients with Coronary Heart Disease: A Meta-Analysis. Chen H; Chen C; Fang J; Wang R; Nie W; Yuan Q Med Sci Monit; 2019 Jul; 25():5473-5481. PubMed ID: 31335859 [TBL] [Abstract][Full Text] [Related]